Form D · Other
Emerald Health Sciences Inc.
Vancouver, A1 · CIK 0001728413
Offering snapshot reported Sep 1, 2022 · SEC filing
- Reported sold
- $65.5K Offering amount: $65.5K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 1, 2022 | Initial | $65,509 | No comparison | 6 | SEC filing |
| Sep 1, 2022 | Initial | $500,430 | No comparison | 10 | SEC filing |
| Sep 1, 2022 | Initial | $392,956 | No comparison | 5 | SEC filing |
| Sep 1, 2022 | Initial | $4,015,359 | No comparison | 45 | SEC filing |
| Sep 1, 2022 | Initial | $9,886,884 | No comparison | 39 | SEC filing |
| Sep 1, 2022 | Initial | $360,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-457764
CAD$1.2789=USD1.00
Source: Form D, filed Sep 1, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Hall | Executive |
| Jim Heppell | Director, Executive |
| Gaetano Morello | Director |
Issuer details
Industry: Other (See others in industry)
Address:
Office 8262 The Landing, 200 375 Water St.
Vancouver, A1, V6B 0M9
Vancouver, A1, V6B 0M9